Backs Q2 revenue view $270M-$280M, consensus $283.97M . Raises Q2 adjusted EBITDA view to $25M-$31M from $22M-$30M. The company said, “On May 12th, 2025, it was announced that the United States would temporarily lower tariff rates on imports from China from 145% to 30% for 90 days. As a result of this announcement, the Company has updated its previously issued second quarter and full year 2025 outlook. The table below contains the previous and updated guidance.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell announces new products for perioperative and clinic settings
- Omnicell opens new Innovation Lab in Austin, Texas
- Omnicell upgraded to Overweight from Equal Weight at Wells Fargo
- Positive Outlook for Omnicell: Strong Demand and Market Stability Drive Buy Rating
- Omnicell price target lowered to $53 from $64 at Craig-Hallum